# DeepSight Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/deepsight-technology

- Industry: Medical Devices & Equipment
- Headquarters: Clayton, US
- Website: www.deepsightinc.com
- Total disclosed funding: $28M
- Latest round: Series A (Sep 3, 2021)
- Investors on record: 4

## About

DeepSight Technology, Inc. specializes in innovative medical imaging solutions, focusing on advancing ultrasound imaging modalities that enhance safety, speed, affordability, and accessibility for healthcare providers.Founded in 2019 and headquartered in Clayton, US, DeepSight Technology, Inc. focuses on the development of medical imaging solutions. The company has raised USD 27.58 mn in Series A funding led by Deerfield Management, with participation from Alter Venture Partners, Time BioVentures, and Wing. The most recent funding round occurred on September 3, 2021, bringing the total amount raised to USD 27.58 mn and valuing the company at USD 58.58 mn. The founders of DeepSight include Alexander Meier, Anand Chandrasekher, and David K.DeepSight Technology specializes in advanced medical imaging solutions, focusing on ultrasound imaging modalities that prioritize safety, speed, affordability, and accessibility. Their core offerings include state-of-the-art general imaging systems and innovative catheter-based ultrasound technologies aimed at improving diagnostic accuracy and patient outcomes. The primary end users of these products are healthcare providers such as hospitals, clinics, and diagnostic imaging centers, seeking to enhance their imaging capabilities and streamline patient care. DeepSight actively collaborates with leading companies in the medical sector to integrate their technology into existing systems, fostering advancements in healthcare services. Their geographical markets extend beyond the United Kingdom, with a presence in various international regions, including Europe and North America.DeepSight Technology's revenue model is structured around direct sales and potential subscription-based partnerships with healthcare institutions. Clients, including hospitals and imaging centers, engage with the company to procure their imaging systems, with transactions typically facilitated through contracts and ongoing service agreements. Flagship products, such as the DeepSight imaging systems, are priced competitively to enhance market penetration. The company’s revenue is bolstered by strategic collaborations and alliances that enable them to expand their market reach and improve product offerings. By focusing on both direct sales and partnerships, DeepSight aims to create sustainable revenue streams while delivering advanced imaging solutions to the healthcare community.DeepSight Technology plans to utilize its recent Series A funding of USD 27.58 mn to support the development of new products and to expand into new markets. The company is designing innovative ultrasound systems aimed at improving diagnostic capabilities in healthcare settings, with anticipated launches in the upcoming year. Additionally, DeepSight is targeting expansion into European and North American markets, enhancing its presence and accessibility by the end of 2023. The funding will facilitate these initiatives, ensuring the company can continue to advance its technology and reach a broader client base.

## Funding rounds

- Series A, Sep 3, 2021, $28M — Deerfield Management, Wing, Time BioVentures, Alter Venture Partners

## Investors

- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series A
- Wing (https://capitalatlas.ai/funds/wing) — Series A
- Time BioVentures (https://capitalatlas.ai/funds/time-bioventures) — Series A
- Alter Venture Partners (https://capitalatlas.ai/funds/alter-venture-partners) — Series A